Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AB-101 for Nipple Sensitivity in Breast Cancer Survivors
NCT03592121Phase 1Completed
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in sexual dysfunction comparing AB-101 with Placebo (2 arms). Primary endpoint: Change in Delayed Orgasm Grade at week 8. Started Jul 2018; status: completed.
02
Drugs
phenylephrine
03
Conditions
sexual dysfunction
Beyond the preview
Go deeper on NCT03592121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592121.